Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results